The Journal of Organic Chemistry
Note
bromomethylfumarate (72 mg, 0.3 mmol), DABCO (39 mg, 0.315
mmol), and butanal (0.16 mL, 1.8 mmol), the crude material was
purified by flash column chromatography on silica gel (eluting with
hexane/ethyl acetate 90/10) to give the title compound as a colorless
oil. Yield: 66% (45 mg). Spectroscopic data of the major diastereomer:
1H NMR (300 MHz, CDCl3) δ 9.59 (d, J = 2.6 Hz, 1H), 6.43 (s, 1H),
5.82 (s, 1H), 4.00 (d, J = 8.7 Hz, 1H), 3.78 (s, 3H), 3.71 (s, 3H),
97/3, flow rate = 0.5 mL/min, tR = 15.5 min, tR = 19.2 major); HRMS
C22H22O3 [M + H]+ calcd 335.1647, found 335.1663.
(3R,4R)-Methyl 4-Formyl-3-methoxycarbonyl-2-methylene-
hept-6-enoate (6Cj) (entry 9, Table2). Starting from dimethyl
bromomethylfumarate (72 mg, 0.3 mmol), DABCO (39 mg, 0.315
mmol), and 4-pentenal (0.18 mL, 1.8 mmol), the crude material was
purified by flash column chromatography on silica gel (eluting with
hexane/ethyl acetate 98/2) to give the title compound as a colorless
oil. Yield: 64% (46 mg). Spectroscopic data of the major diastereomer:
1H NMR (300 MHz, CDCl3) δ 9.65 (d, J = 1.8 Hz, 1H), 6.43 (s, 1H),
2.90−2.80 (m, 1H), 1.81−1.69 (m, 2H), 0.93 (t, J = 3.6 Hz, 3H); 13
C
NMR (75 MHz, CDCl3) δ 202.0, 171.9, 166.3, 136.1, 128.7, 54.7, 52.3,
45.8, 20.5, 11.5. The diastereomeric ratio (87:13) was determined by
1H NMR. The enantiomeric excess was determined by HPLC with
5.81 (s, 1H), 5.78−5.65 (m, 1H), 5.07 (dd, J = 1.5, 5.3 Hz, 2H), 4.00
(d, J = 8.0 Hz, 1H), 3.77 (s, 3H), 3.71 (s, 3H), 3.10−3.02 (m, 1H),
2.57−2.50 (m, 1H), 2.37−2.31 (m, 1H); 13C NMR (75 MHz, CDCl3)
δ 201.6, 171.8, 166.1, 135.8, 134.2, 129.1, 127.4, 118.1, 52.4, 45.9, 31.3.
Chiralpack IC column at 209.8 nm (hexane/iPrOH in the ratio of 90/
10, flow rate = 0.5 mL/min, tR = 48.8 min (mayor), tR = 53.3 min
(minor)); HRMS C11H16O5 [M + H]+ calcd 229.1076, found
229.1075.
1
The diastereomeric ratio (82:18) was determined by H NMR. The
enantiomeric excess was determined by HPLC with Chiralpack IC
column at 209.8 nm (hexane/iPrOH in the ratio of 90/10, flow rate =
0.5 mL/min, tR = 37.5 min (minor), tR = 44.7 min (major)); HRMS
C12H17O5 [M + H]+ calcd 241.1076, found 241.1083.
(3S,4R)-Phenyl 3-(4-Chlorophenyl)-4-formyl-2-methyleneoc-
tanoate (6Bf) (Entry 6, Table 2). Starting from (Z)-phenyl 2-
(bromomethyl)-3-(4-chlorophenyl)acrylate (106 mg, 0.3 mmol),
DABCO (39 mg, 0.315 mmol), and hexanal (0.22 mL, 1.8 mmol),
the crude material was purified by flash column chromatography on
silica gel (eluting with hexane/ethyl acetate 98/2) to give the title
compound as a yellow oil. Yield: 50% (57 mg). Spectroscopic data of
(3S,4R)-Phenyl 8-(tert-Butoxycarbonylamino)-3-(4-chloro-
phenyl)-4-formyl-2-methyleneoctanoate (6Df) (Entry 10,
Table 2). Starting from (Z)-phenyl 2-(bromomethyl)-3-(4-
chlorophenyl)acrylate (106 mg, 0.3 mmol), DABCO (39 mg, 0.315
mmol) and 6-(N-Boc-amino)hexanal (387 mg, 1.8 mmol). The crude
material was purified by flash column chromatography on silica gel
(eluting with hexane/ethyl acetate 90/10) to give the title compound
as a yellow oil. Yield: 87% (127 mg). Spectroscopic data of the major
1
the major diastereomer: H NMR (300 MHz, CDCl3) δ 9.56 (d, J =
4.7 Hz, 1H), 7.36−7.18 (m, 7H), 6.99 (d, J = 8.4 Hz, 2H), 6.58 (s,
1H), 5.91 (d, J = 0.9 Hz, 1H), 4.20 (d, J = 11.5 Hz, 1H), 3.01−2.91
(m, 1H), 1.38−1.06 (m, 6H), 0.92−0.86 (m, 3H); 13C NMR (75
MHz, CDCl3) δ 203.3, 150.6, 141.0, 138.0, 133.1, 130.1, 126.0, 121.5,
54.9, 45.8, 28.7, 22.5, 13.7. The diastereomeric ratio (92:8) was
1
diastereomer: H NMR (300 MHz, CDCl3): δ 9.60 (d, J = 4.2 Hz,
1H), 7.38−7.23 (m, 7H), 7.00 (d, J = 7.4 Hz, 2H), 6.61 (s, 1H), 5.95
(s, 1H), 4.23 (d, J = 11.5 Hz), 3.18−3.09(m, 1H), 3.07−2.96 (m, 2H),
1.51−1.48 (m, 2H), 1.47 (s, 3H), 1.46 (s, 6H), 1.41−1.31 (m, 4H);
13C NMR (75 MHz, CDCl3) δ 202.0, 164.7, 155.9, 150.6, 140.9, 137.8,
133.2, 129.4, 129.0, 127.6, 126.0, 121.4, 70.8, 54.8, 45.8, 40.1, 30.0,
28.4, 27.7, 23.8. The diastereomeric ratio (90:10) was determined by
1H NMR. The enantiomeric excess was determined by HPLC with
1
determined by H NMR.The enantiomeric excess was determined by
HPLC with Chiralpack IB column at 210 nm (hexane/iPrOH in the
ratio of 99/1, flow rate = 0.5 mL/min, tR = 15.9 min, tR = 18.2 major);
HRMS C22H24ClO3 [M + H − C6H5O]+ calcd 277.0995, found
277.1002.
(3S,4R)-Phenyl 3-(4-Chlorophenyl)-4-formyl-2-methylene-
hept-6-enoate (6Cf) (Entry 7, Table 2). Starting from (Z)-phenyl
2-(bromomethyl)-3-(4-chlorophenyl)acrylate (106 mg, 0.3 mmol),
DABCO (39 mg, 0.315 mmol), and 4-pentenal (0.18 mL, 1.8 mmol),
the crude material was purified by flash column chromatography on
silica gel (eluting with hexane/ethyl acetate 95/5) to give the title
compound as a yellow oil. Yield: 78% (84 mg). Spectroscopic data of
Chiralpack IC column at 254 nm (hexane/iPrOH in the ratio of 80/
20, flow rate =0.5 mL/min, tR = 42.5 min (major), tR = 46.2 min
(minor); HRMS C27H33ClNO5 [M + H − C5H10O2]+ calcd 368.1417,
found 368.1416.
(3S,4R)-Phenyl 3-(4-Chlorophenyl)-4-formyl-6,6-dimethoxy-
2-methylenehexanoate (6Ef) (Entry 11, Table 2). Starting from
4,4-dimethoxybutanal (3 mmol, 3 equiv), (Z)-phenyl 2-(bromometh-
yl)-3-(4-chlorophenyl)acrylate (176 mg, 0.5 mmol), and DABCO
(56.1 mg, 0.51 mmol) at room temperature for 60 h according to the
general procedure: yield 69% (140 mg) (diastereomeric ratio 5:1); 1H
NMR (major diastereoisomer) (300 MHz, CDCl3) δ 9.67 (d, J = 3.3
Hz, 1H), 7.40−7.18 (m, 7H), 7.00−6.96 (m, 2H), 6.59 (s, 1H), 5.97
(d, 1H, J = 0.9 Hz), 4.26−4.20 (m, 2H), 3.24 (s, 3H), 3.22 (s, 3H),
1.90−1.80 (m, 2H), 1.63−1.53 (m, 1H); 13C NMR (major
diastereoisomer) (75 MHz, CDCl3) δ 202.5, 164.6, 150.6, 140.6,
137.8, 133.2, 130.0, 129.9, 129.4, 128.9, 127.5, 125.9, 121.4, 103.0,
54.2, 53.3, 50.2, 46.1, 32.5. The diastereomeric ratio (81:19) was
determined by 1H NMR. The enantiomeric excess was determined by
HPLC with Chiralpack IA column at 254 nm (hexane/iPrOH in the
ratio of 98/2, flow rate = 0.5 mL/min, tR = 31.9 min (major), tR = 46.7
min (minor)).
1
the major diastereomer: H NMR (300 MHz, CDCl3) δ 9.63 (d, J =
3.6 Hz, 1H), 7.39−7.29 (m, 4H), 7.25−7.18 (m, 3H), 7.00−6.96 (m,
2H), 6.58 (s, 1H), 5.91 (d, J = 1.0 Hz, 1H), 5.63 (dt, J = 8.5, 8.5, 17.1
Hz, 1H), 5.08−4.92 (m, 2H), 4.28 (d, J = 11.4 Hz, 1H), 3.14 (dd, J =
3.6, 11.4 Hz, 1H), 2.19 (t, J = 6.5 Hz, 2H); 13C NMR (75 MHz,
CDCl3) δ 202.8, 164.7, 150.6, 140.8, 137.6, 135.6, 133.3, 130.0, 129.4,
128.9, 127.3, 125.9, 121.4, 118.1, 54.1, 45.3, 32.5. The diastereomeric
1
ratio (91:9) was determined by H NMR. The enantiomeric excess
was determined by HPLC with Chiralpack IC column at 254 nm
(hexane/iPrOH in the ratio of 95/5, flow rate =0.5 mL/min, tR = 22.0
min, tR = 25.1 major); HRMS C21H20ClO3 [M + H − C6H5O]+ calcd
261.0682, found 261.0682.
(3S,4R)-Phenyl 4-Formyl-2-methylene-3-p-tolylhept-6-
enoate (6Ch) (Entry 8, Table 2). Starting from (Z)-phenyl 2-
(bromomethyl)-3-p-tolylacrylate (99 mg, 0.3 mmol), DABCO (39 mg,
0.315 mmol), and 4-pentenal (0.18 mL, 1.8 mmol), the crude material
was purified by flash column chromatography on silica gel (eluting
with hexane/ethyl acetate 95/5) to give the title compound as a
colorless oil. Yield: 62% (62 mg). Spectroscopic data of the major
diastereomer: 1H NMR (300 MHz, CDCl3) δ 9.63 (d, J = 3.8 Hz, 1H),
7.34 (t, J = 7.7 Hz 2H), 7.22−7.11 (m, 4H), 7.00−6.96 (m, 2H), 6.83
(d, J = 7.6 Hz, 1H), 6.55 (s, 1H), 5.90 (d, J = 1.0 Hz, 1H), 5.65 (dt, J =
8.6, 17.2 Hz, 1H), 4.98 (dd, J = 6.1, 26.2 Hz, 2H), 4.25 (d, J = 11.4 Hz,
1H), 3.13 (dd, J = 3.9, 11.3 Hz, 1H), 2.34 (s, 3H), 2.38−2.30 (m, 1H),
2.21 (t, J = 6.8, Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 203.5, 165.0,
150.7, 141.4, 133.9, 129.5, 125.8, 121.5, 120.8, 117.8, 115.3, 54.6, 45.6,
(3S,4R)-7-Methyl 1-Phenyl 3-(4-chlorophenyl)-4-formyl-2-
methyleneheptanedioate (6Ff) (Entry 12, Table 2). Starting
from methyl 5-oxopentanoate (3 mmol, 3 equiv), (Z)-phenyl 2-
(bromomethyl)-3-(4-chlorophenyl)acrylate (176 mg, 0.5 mmol), and
DABCO (56.1 mg, 0.51 mmol) at room temperature for 60 h
according to the general procedure: yield 65% (132 mg)
1
(diastereomeric ratio 4:1); H NMR (major diastereoisomer) (300
MHz, CDCl3) 9.59 (d, J = 4.0 Hz, 1H), 7.37−7.30 (m, 3H), 7.27−7.21
(m, 4H), 6.99 (dd, J = 8.4, 9.7 Hz, 2H), 6.60 (s, 1H), 5.94 (s, 1H),
4.24−4.21(m, 1H), 4.08 (t, J = 6.1 Hz, 2H), 3.68 (s, 3H) 2.44−2.38
(m, 2H), 1.74−1.70 (m, 2H); 13C NMR (major diastereoisomer) (75
MHz, CDCl3) δ 202.4, 172.8, 164.6, 150.5, 140.6, 137.3, 133.3, 129.0,
121.4, 63.9, 53.8, 51.6, 51.5, 46.0, 30.8, 28.0, 22.9, 21.4, 20.1. The
diastereomeric ratio (80:20) was determined by 1H NMR. The
1
32.7, 21.0. The diastereomeric ratio (92:8) was determined by H
NMR. The enantiomeric excess was determined by HPLC with
Chiralpack AD-H column at 254 nm (hexane/iPrOH in the ratio of
751
dx.doi.org/10.1021/jo202073n | J. Org. Chem. 2012, 77, 747−753